125 related articles for article (PubMed ID: 29869881)
21. Molecular design and optimization of 99mTc-labeled recombinant affibody molecules improves their biodistribution and imaging properties.
Wållberg H; Orlova A; Altai M; Hosseinimehr SJ; Widström C; Malmberg J; Ståhl S; Tolmachev V
J Nucl Med; 2011 Mar; 52(3):461-9. PubMed ID: 21321280
[TBL] [Abstract][Full Text] [Related]
22. Comparison of in vitro and in vivo properties of [99mTc]cRGD peptides labeled using different novel Tc-cores.
Decristoforo C; Santos I; Pietzsch HJ; Kuenstler JU; Duatti A; Smith CJ; Rey A; Alberto R; Von Guggenberg E; Haubner R
Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):33-41. PubMed ID: 17372571
[TBL] [Abstract][Full Text] [Related]
23. Biodistribution of immunoliposome labeled with Tc-99m in tumor xenografted mice.
Kitamura N; Shigematsu N; Nakahara T; Kanoh M; Hashimoto J; Kunieda E; Kubo A
Ann Nucl Med; 2009 Feb; 23(2):149-53. PubMed ID: 19225938
[TBL] [Abstract][Full Text] [Related]
24. Coordination-Mediated Synthesis of Purification-Free Bivalent
Taira Y; Uehara T; Tsuchiya M; Takemori H; Mizuno Y; Takahashi S; Suzuki H; Hanaoka H; Akizawa H; Arano Y
Bioconjug Chem; 2018 Feb; 29(2):459-466. PubMed ID: 29320158
[TBL] [Abstract][Full Text] [Related]
25. Tc-99m-labeled RGD-conjugated alpha-melanocyte stimulating hormone hybrid peptides with reduced renal uptake.
Yang J; Hu CA; Miao Y
Amino Acids; 2015 Apr; 47(4):813-23. PubMed ID: 25557051
[TBL] [Abstract][Full Text] [Related]
26. Application of 99mTc labeled chimeric Fab fragments of monoclonal antibody A7 for immunoscintigraphy of pancreatic carcinoma.
Otsuji E; Matsumura H; Okamoto K; Toma A; Kuriu Y; Ichikawa D; Hagiwara A; Yamagishi H
J Surg Oncol; 2003 Nov; 84(3):160-5. PubMed ID: 14598360
[TBL] [Abstract][Full Text] [Related]
27. A novel multivalent (99m)Tc-labeled EG2-C4bpα antibody for targeting the epidermal growth factor receptor in tumor xenografts.
Li C; Zhang Y; Wang L; Feng H; Xia X; Ma J; Yuan H; Gao B; Lan X
Nucl Med Biol; 2015 Jun; 42(6):547-54. PubMed ID: 25779037
[TBL] [Abstract][Full Text] [Related]
28. Infection detection in mice using 99mTc-labeled HYNIC and N2S2 chelate conjugated to the antimicrobial peptide UBI 29-41.
Welling MM; Visentin R; Feitsma HI; Lupetti A; Pauwels EK; Nibbering PH
Nucl Med Biol; 2004 May; 31(4):503-9. PubMed ID: 15093821
[TBL] [Abstract][Full Text] [Related]
29. Pretargeting with labeled bivalent peptides allowing the use of four radionuclides: (111)In, (131)I, (99m)Tc, and (188)Re.
van Schaijk FG; Oosterwijk E; Soede AC; Oyen WJ; McBride WJ; Griffiths GL; Goldenberg DM; Corstens FH; Boerman OC
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3880S-5S. PubMed ID: 14506186
[TBL] [Abstract][Full Text] [Related]
30. Introduction of an 8-aminooctanoic acid linker enhances uptake of 99mTc-labeled lactam bridge-cyclized α-MSH peptide in melanoma.
Guo H; Miao Y
J Nucl Med; 2014 Dec; 55(12):2057-63. PubMed ID: 25453052
[TBL] [Abstract][Full Text] [Related]
31. Radiolabeling of fab and f(ab')2 antibody fragments with 99mTc(I) tricarbonyl core using a new bifunctional tridentate ligand.
Misri R; Saatchi K; Häfeli UO
Nucl Med Commun; 2011 Apr; 32(4):324-9. PubMed ID: 21285909
[TBL] [Abstract][Full Text] [Related]
32. Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imaging.
Olafsen T; Kenanova VE; Sundaresan G; Anderson AL; Crow D; Yazaki PJ; Li L; Press MF; Gambhir SS; Williams LE; Wong JY; Raubitschek AA; Shively JE; Wu AM
Cancer Res; 2005 Jul; 65(13):5907-16. PubMed ID: 15994969
[TBL] [Abstract][Full Text] [Related]
33. 99mTc-chelator engineering to improve tumour targeting properties of a HER2-specific Affibody molecule.
Engfeldt T; Tran T; Orlova A; Widström C; Feldwisch J; Abrahmsen L; Wennborg A; Karlström AE; Tolmachev V
Eur J Nucl Med Mol Imaging; 2007 Nov; 34(11):1843-53. PubMed ID: 17565496
[TBL] [Abstract][Full Text] [Related]
34. Dual MVK cleavable linkers effectively reduce renal retention of
Valpreda G; Trachsel B; Vogel V; Schibli R; Mu L; Behe M
Bioorg Med Chem; 2022 Nov; 73():117040. PubMed ID: 36202066
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of 99mTc-Z IGF1R:4551-GGGC affibody molecule, a new probe for imaging of insulin-like growth factor type 1 receptor expression.
Mitran B; Altai M; Hofström C; Honarvar H; Sandström M; Orlova A; Tolmachev V; Gräslund T
Amino Acids; 2015 Feb; 47(2):303-15. PubMed ID: 25425114
[TBL] [Abstract][Full Text] [Related]
36. Molecular imaging and pharmacokinetics of (99m) Tc-hTERT antisense oligonucleotide as a potential tumor imaging probe.
Liu M; Wang RF; Yan P; Zhang CL; Cui YG
J Labelled Comp Radiopharm; 2014 Feb; 57(2):97-101. PubMed ID: 24307558
[TBL] [Abstract][Full Text] [Related]
37. 99mTc-labeled divalent and tetravalent CC49 single-chain Fv's: novel imaging agents for rapid in vivo localization of human colon carcinoma.
Goel A; Baranowska-Kortylewicz J; Hinrichs SH; Wisecarver J; Pavlinkova G; Augustine S; Colcher D; Booth BJ; Batra SK
J Nucl Med; 2001 Oct; 42(10):1519-27. PubMed ID: 11585867
[TBL] [Abstract][Full Text] [Related]
38. Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives.
Behr TM; Sharkey RM; Juweid ME; Blumenthal RD; Dunn RM; Griffiths GL; Bair HJ; Wolf FG; Becker WS; Goldenberg DM
Cancer Res; 1995 Sep; 55(17):3825-34. PubMed ID: 7641200
[TBL] [Abstract][Full Text] [Related]
39. Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations.
Behr TM; Goldenberg DM; Becker W
Eur J Nucl Med; 1998 Feb; 25(2):201-12. PubMed ID: 9473271
[TBL] [Abstract][Full Text] [Related]
40. Tissue-targeting lead generation and optimization from random and directed screening of technetium-99m labeled tripeptide complex libraries in vivo.
Zeng J; Liu CY; Xie WH; Hu SL; Jin MX
Chin Med J (Engl); 2006 Sep; 119(17):1435-43. PubMed ID: 16989744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
